PSP Clinical Director, Peter Sanderson, has contributed to an internationally presented education framework focused on advancing ultrasound-guided spasticity management.
The work was presented at the International Society of Physical and Rehabilitation Medicine World Congress 2026 in Vancouver, Canada, as part of the MUSICA (Muscle Ultrasound for Spasticity Intelligent Care) Education Program.
Developed by an international faculty of clinicians and experts in spasticity management, the MUSICA framework aims to support clinicians in improving confidence, precision, and clinical decision-making when using musculoskeletal ultrasound during botulinum toxin treatment planning.

The framework is centred around five clinical pearls designed to strengthen anatomy learning, improve muscle localisation, assess architectural muscle changes, and support best practice in ultrasound-guided intervention.
The study evaluated the impact of the MUSICA curriculum through structured knowledge checks and participant feedback surveys. Preliminary results demonstrated strong improvements in physician knowledge and procedural confidence following attendance at MUSICA workshops.

Across three workshops, more than 90% of attendees endorsed the value of the MUSICA framework within daily clinical practice and reported high satisfaction with the workshop content.
Peter Sanderson said:
“Ultrasound-guided spasticity management continues to evolve, and frameworks such as MUSICA implement evidenced based practice in optimising patient outcomes. The training programme is internationally recognised bringing together world key opinion leaders to allow clinicians to enhance both technical and clinical decision-making skills. It’s encouraging to see international collaboration focused on improving outcomes for patients living with complex neurological conditions.”
At PSP, advanced spasticity management forms a key part of our specialist neurorehabilitation offering, with services supporting both adults and children with complex neurological presentations.
Our team continues to remain actively involved in education, training, and the development of best practice within neurorehabilitation and spasticity management.